The impact of intestinal failure on oral drug absorption: A Review

Journal of Gastrointestinal Surgery

Volumn 14, Issue 6, 2010, Pages 1045-1051

  Ward, Nicola ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Absorption, intestinal; Oral drug administration; Short bowel syndrome; Stomas, surgical

Indexed keywords

ARTICLE; ENTEROPATHY; HUMAN; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHARMACOKINETICS; PHYSIOLOGY; SMALL INTESTINE;

ADMINISTRATION, ORAL; HUMANS; INTESTINAL ABSORPTION; INTESTINAL DISEASES; INTESTINE, SMALL; PHARMACOKINETICS;

EID: 77952545834     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1151-9     Document Type: Article

References (36)

1. O'Keefe SJD, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clinical Gastroenterology and Hepatology 2006; 4: 6-10.
2. American Gastroenterological Association. Medical position statement: Short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1105-1110.
3. McFadden MA, DeLegge MH, Kirby DF. Medication delivery in the short-bowel syndrome. Journal of Parenteral and Enteral Nutrition 1993; 17: 180-186.
4. Parsons RL. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes. Clinical Pharmacokinetics 1977; 2: 45-60.
5. Dickerson RN, Melnik G. Osmolality of oral drug solutions and suspensions. American Journal of Hospital Pharmacy 1988; 45: 832-834.
6. Lutomski DM, Gora ML, Wright SM, Damaldy IC, Chayer S. Sorbitol content of selected oral liquids. Annals of Pharmacotherapy 1993; 27: 269-274.
7. Hill DB, Henderson LM, McClain CJ. Osmotic diarrhoea induced by sugar-free theophylline solution in critically ill patients. Journal of Parenteral and Enteral Nutrition 1991; 15: 332-336.
8. Bongaerts GP, Tolboom JJ, Naber AH, Speri WJ, Serverijnen RS, Bakkeren JA. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microbial Pathogenesis 1997; 22: 285-293.
9. Thomson FC, Naysmith MR, Lindsay A. Managing drug therapy in patients receiving enteral and parenteral nutrition. Hospital Pharmacist 2000; 7: 155-164.
10. Gubbins PO, Bertch KE. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications. Clinical Pharmacokinetics 1991; 21: 431-447.
11. Russo Jr J, Watson WA, Nelson EW. Cimetidine bioavailability after massive small bowel resection. Clinical Pharmacy 1982; 1: 558-561.
12. Mitchell JF, Maas LC, Barger RC, Gelzayd EA. Successful oral anticoagulation therapy in a patient with short bowel syndrome. American Journal of Hospital Pharmacy 1977; 24: 171-172.
13. Lutomski DM, LaFrance RJ, Bower RH, Fischer JE. Warfarin absorption after massive small bowel resection. American Journal of Gastroenterology 1985; 80: 99-102.
14. Lehman ME, Kolb KW, Barnhart GR, Wagman LD, Barr WH. Warfarin absorption in a patient with short-bowel syndrome. Clinical Pharmacy 1985; 4: 325-326.
15. Kearns RJ, O'Reilly RA. Bioavailability of warfarin in a patient with severe short bowel syndrome. Journal of Parenteral and Enteral Nutrition 1986; 10: 100-101.
16. Owens JP, Mirtallo JM, Murphy CC. Oral anticoagulation in patients with short-bowel syndrome. Annals of Pharmacotherapy 1990; 24: 585-589.
17. Lutomski DM, Palascak JE, Bower RH. Warfarin resistance associated with intravenous lipid administration. Journal of Parenteral and Enteral Nutrition 1987; 11: 316-318.
18. Baxter and Stockley. Stockley's Drug Interactions. London: Pharmaceutical Press, 2007.
19. Brophy DF, Ford SL, Crouch MA. Warfarin resistance in a patient with short bowel syndrome. Pharmacotherapy 1998; 18: 646-649.
20. Vetticaden SJ, Lehman ME, Barnhart GR, Barr WH. Digoxin absorption in a patient with short-bowel syndrome. Clinical Pharmacy 1986; 5: 62-64.
21. Krauz MM, Berry E, Freund U, Levy M. Absorption of orally administered digoxin after massive resection of the small bowel. American Journal of Gastroenterology 1979; 71: 220-223.
22. Heizer WD, Pittman AW, Hammond JE, Fitch DD, Bustrack JA, Hull JH. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes. DICP Annals of Pharmacotherapy 1989; 23: 764-769.
23. Kennedy JM, van Riji AM. Effects of surgery on the pharmacokinetic parameters of drugs. Clinical Pharmacokinetics 1998; 35: 293-312.
24. Ehrenpreis ED, Guerriero S, Nogueras JJ, Carroll MA. Malabsorption of digoxin tablets, gel caps, and elixir in a patient with an end jejunostomy. Annals of Pharmacotherapy 1994; 28: 1239-1240.
25. Silomon M, Bach F, Juckenhöfel S, Claus T, Molte G. Bioverfügbarkeit von Sotalol bei verkürzter gastrointestinaler passage. [Bioavailability of sotalol in short bowel syndrome: English abstract]. Medizinische Klinik 1999; 94: 638-641.
26. Evard D, Aubry JP, Le Quintrec Y, Cheymol G, Cheymol A. Study of the bioavailability of pindolol in malabsorption syndromes. British Journal of Clinical Pharmacology 1984; 18: 632-637.
27. Robbins B, Reiss RA. Amitriptyline absorption in a patient with short bowel syndrome. American Journal of Gastroenterology 1999; 94: 2302-2304.
28. Broyles JE, Brown RO, Self TH, Frederick RC, Luther RW. Nortriptyline absorption in short bowel syndrome. Journal of Parenteral and Enteral Nutrition 1990; 14: 326-327.
29. Ueno T, Tanaka A, Hamanaka Y, Suzuki T. Serum drug concentrations after oral administration of paracetamol to patients with surgical resection of the gastrointestinal tract. British Journal of Clinical Pharmacology 1995; 39: 330-332.
30. Stone E, Leiter LA, Lambert JR, Silverberg JDH, Jeejeebhoy KN, Burrow GN. L-Thyroxine absorption in patients with short bowel. Journal of Clinical Endocrinology and Metabolism 1984; 59: 139-141.
31. Roberts R, Sketris IS, Abraham I, Givner ML, MacDonald AS. Ciclosporine absorption in two patients with short-bowel syndrome. Drug Intelligence and Clinical Pharmacy 1988; 22: 570-572.
32. Theilke J, Weber FL, Schroeder TJ, Goretsky S, Hanto DW. Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndrome. Liver Transplantation and Surgery 1998; 4: 432-434.
33. Mindel A, Carney O. Acyclovir malabsorption. British Medical Journal 1988; 296: 1605.
34. Joe LA, Jacobs RA, Guglielmo BJ. Systemic absorption of oral fluconazole after gastrointestinal resection [letter]. Journal of Antimicrobial Chemotherapy 1994; 33: 1070.
35. Nahata MC, Freimer N, Hilty MD. Decreased absorption of cefaclor in short bowel syndrome. Drug Intelligence and Clinical Pharmacy 1983; 17: 201-202.
36. Menardi G, Guggenbichler JP. Bioavailability of oral antibiotics in children with short-bowel syndrome. Journal of Paediatric Surgery 1984; 19: 84-86.